https://www.selleckchem.com/products/pk11007.html
8%]), sodium/calcium polystyrene sulphonate (135patients [45.8%]), a low-potassium diet (31patients [10.5%]) and sodium bicarbonate (31patients [10.5%]). Between the two consecutive hyperkalaemic episodes documented, the proportion of patients on renin-angiotensin-aldosterone system inhibitors treatment decreased from 42.4% to 34.6%. Renin-angiotensin-aldosterone system inhibitors treatment interruptions were observed in the setting of recurrent hyperkalaemic episodes. Recurrent hyperkalaemia is a major cause of hospitalizations. More e
Like
Comment
Share
